Published on May 26, 2015

The India government is aiming towards implementing such policies which increases the access to healthcare in rural and in urban sector. Emphasizing on the healthcare insurance will increases the scope for further grown in pharmaceutical sector. The focus of industry towards still unexplored markets of rural India will provide more opportunity for the manufacturers to grow. In current scenario drug sales in rural market is growing at a higher rate than in urban markets. Further rural markets do make the manufacturers to realize the importance of price control policy.

Indian government has been focusing on cost-effective RnD policies. Availability of cheap and skilled labor is one of the distinctive advantages for this industry. The government of India is focusing on making India the Drug Discovery and Global Pharma Innovation hub by 2020. The Indian pharma industry is able to capitalize on its strong points of cheap labor and low production and low RnD cost. India is one of the leading exporters to US, France, Germany and UK. The country is focusing on inclusion of other drugs in its list and extends its market to the other developing nations as well.